Octavio Espinoza - 15 Feb 2023 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Financial Officer
Signature
/s/ Andrew Reardon, Attorney-in-Fact for Octavio Espinoza
Issuer symbol
LGND
Transactions as of
15 Feb 2023
Net transactions value
-$61,960
Form type
4
Filing time
17 Feb 2023, 18:20:39 UTC
Previous filing
04 Jan 2023
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $61,960 -849 -4.5% $72.98 18,096 15 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.